Scientific awards are of major importance for all scientists to move forward in their career. Receiving an award highlights the importance of your work and, moreover helps you to gain a significant amount of visibility and impact. Additionally, applying for (third party) funding and expansion of your professional network will also benefit after receiving an award.
Announcements for September 2023
Excellent Paper In Neuroscience - Award 2023
EPNA AWARD 2023 - Thematic focus on Neurodevelopmental Disorders
The ERA-NET NEURON partner countries are issuing the EXCELLENT PAPER IN NEUROSCIENCE AWARD to recognize the remarkable and outstanding scientific publications by early-career researchers in the field of disease-related, translational, neurosciences. Sole First Author of original research articles published between January 1, 2022, and December 31, 2022, and affiliated with the call partner countries listed below are eligible to apply.
An award of EUR 3 000 will be granted to the best proposal. The winner will be invited as an “Excellent Paper in Neuroscience” special lecturer during the FENS Forum on 25-29th of June 2024, in Vienna, Austria. ERA-NET NEURON will cover the award and travel costs related to the lecture.
ESMI Award for excellent PhD Thesis – Apply now!
The society’s PhD Award for excellent PhD thesis is offered to encourage and reward outstanding research in the broad field of imaging science conducted by our early career members as part of their doctoral work.
Currently applications are accepted with date of thesis defence between October 2022 and September 2023!
More information: https://e-smi.eu/about/awards/phd-award/
Michelson Philanthropies & Science Prize for Immunology
The Michelson Philanthropies & Science Prize for Immunology focuses on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery. This international prize is intended to encourage and support young investigators from a wide range of disciplines, including computer science, artificial intelligence/machine learning, protein engineering, nanotechnology, genomics, parasitology and tropical medicine, neurodegenerative diseases, and gene editing, who apply their expertise to perform research that has a lasting impact on vaccine and immunotherapy.
Applicants must be no older than thirty-five (35) years of age and must hold an M.D., PhD., or M.D./Ph.D. at the time of entry.